寻找中国自免之王

医曜
Yesterday

本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。BD为王的核心逻辑下,中国药企BD交易总额近在上半年创出608亿元的新高。然而,当BD预期已经释放到极致,市场对于BD交易的敏锐度则已经开始下降。10月17日,5家国内药企同时宣布达成出海授权,总金额达数十亿美元,但股价却是高开低走。10月22日,信达生物达成114亿美元大单,同样难挡股价下跌。从这不难看出,见惯了大手笔BD交易的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10